NPI: 1316971641 · RIVERSIDE, CA 92505 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/11/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/11/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 36,306 | $1.77M |
| 2019 | 43,339 | $2.11M |
| 2020 | 39,965 | $1.96M |
| 2021 | 45,836 | $2.10M |
| 2022 | 45,871 | $1.94M |
| 2023 | 44,427 | $2.05M |
| 2024 | 25,738 | $1.86M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 92,525 | 7,801 | $13.55M |
| A4657 | Syringe, with or without needle, each | 6,507 | 3,710 | $215K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 74,760 | 5,612 | $10K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,418 | 849 | $3K |
| 0250 | 13,138 | 922 | $846.08 | |
| 82728 | 1,950 | 1,880 | $777.79 | |
| J2501 | Injection, paricalcitol, 1 mcg | 43,151 | 3,426 | $651.20 |
| 90677 | 21 | 19 | $624.18 | |
| J1756 | Injection, iron sucrose, 1 mg | 22,955 | 5,730 | $600.36 |
| 90661 | 15 | 15 | $417.18 | |
| 82108 | 299 | 292 | $71.03 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 7,071 | 619 | $39.12 |
| 83970 | 2,817 | 2,699 | $34.84 | |
| 83550 | 2,319 | 2,193 | $8.15 | |
| 83540 | 2,772 | 2,616 | $6.66 | |
| 85041 | 3,327 | 3,158 | $3.11 | |
| 85048 | 3,285 | 3,120 | $0.37 | |
| 85045 | 432 | 403 | $0.00 | |
| 90662 | 96 | 96 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,112 | 881 | $0.00 |
| 90747 | 24 | 24 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 127 | 127 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 14 | 14 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,093 | 1,065 | $0.00 |
| 90674 | 215 | 204 | $0.00 | |
| 82746 | 12 | 12 | $0.00 | |
| 82607 | 13 | 13 | $0.00 | |
| 87340 | 14 | 14 | $0.00 |